Regeneron’s Drug Becomes First FDA-Approved Ebola Virus Treatment
1 sourceUpdated Oct 14, 2020
The U.S. Food and Drug Administration on Wednesday approved Regeneron Pharmaceuticals’ triple antibody cocktail as the first Ebola virus treatment, lending validation to similar drugs being developed for COVID-19…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Coverage
Comments
Ask this story anything:
Free account · your comment posts right after signup

